Submit your Rss Feed Link Below

Friday, April 23, 2010

Oncology Discussions and Cancer Views from ASCO, ASH, SABCS and more -

ECCO 15 ESMO 34 - Costs of licensing clinical trials


Prof. John Smyth, Assistant Principal for Cancer Research Development at University of Edinburgh, discusses the issue of the cost of licensing trials with managing editor Professor Gordon McVie, at EC...



Author: ecancertv

Added: 04/23/2010


ECCO 15 ESMO 34 - Young people with cancer


Dr Jeremy Whelan discusses cancer care for adolescents, specifically looking at the issues faced by young people and how their needs can be addressed.



Author: ecancertv

Added: 04/23/2010


ECCO 15 - ESMO 34 Guidelines for safer handling of cytotoxics


Dr Klaus Meier, President of the European Society of Oncology Pharmacy, discusses the society's latest work of preparing centralised guidelines for the preperation of cytotoxic treatments with managin...



Author: ecancertv

Added: 04/23/2010


ECCO 15 ESMO 34 - Circulating tumour cells


Anieta Sieuwerts of the Erasmus University in Rotterdam discusses the research presented on circulating tumour cells at ECCO 15 - ESMO 34 in Berlin 2009.



Author: ecancertv

Added: 04/23/2010


ECCO 15 ESMO 34 - Early detection of cancer


Prof. Ron Laskey, University of Cambridge, talks about research into identifying malignant and pre-malignant cells in body fluids for the early detection of cancer.



Author: ecancertv

Added: 04/23/2010


ECCO 15 ESMO 34 - PET in the treatment of Hodgkin's Lymphoma


Dr Lena Specht discusses the use of PET imaging in the treatment of Hodgkin's Lymphoma.



Author: ecancertv

Added: 04/23/2010


ECCO 15 ESMO 34 - Triple negative breast cancer


Features of triple negative breast cancer and various cancers within the triple negative grouping. PARP inhibitors. Grouping tumours by similarity to BRCA 1- 'BRCAness'. Multidisciplinary teams.



D...



Author: ecancertv

Added: 04/23/2010


ECCO 15 ESMO 34 - Prioritisation in cancer research


Prof Sullivan discusses the current European and global effort to prioritise different areas of cancer research.



Prof Richard Sullivan of King's College, London, speaking to Prof Gordon McVie, Man...



Author: ecancertv

Added: 04/23/2010


ECCO 15 ESMO 34 - The problems of getting new molecules to the clinic


Newer mouse models needed for testing drugs. Need to reduce failure rate of new drugs. Academia's role in drug development. Epigenetic targets.



Prof Mariano Barbacid of the Spanish National Cancer ...



Author: ecancertv

Added: 04/23/2010


Dr. Umberto Veronesi - Six Weeks of Radiation Therapy May Be Unnecessary for Many Breast Cancer Patients


Renowned surgeon Dr. Umberto Veronesi, founder of the European Institute of Oncology, shared for the first time the results of a long-awaited, eight-year randomized trial comparing his breast cancer p...



Author: medized

Added: 04/22/2010


ECCO 15 ESMO 34 Current situation with aromatase inhibitors


Prof Charles Coombes of the Imperial College School of Medicine, London, UK, speaking at ECCO 15 - ESMO 34, Sept 2009, Berlin:



Current situation with aromatase inhibitors. Increase in disease free...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - European Association for Cancer Research


Prof Anne-Lise Borresen-Dale - President of the European Association for Cancer Research, speaking at ECCO 15 - ESMO 34, Sept 2009, Berlin, about her work leading basic science against cancer.



Author: ecancertv

Added: 04/22/2010


The latest advances in radiation oncology


What's driving radiation oncologists at the moment? Changing practice to take into account genetic information on resistance to radiation. Combining genetic information with imaging. Normal tissue rea...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Radioimmunotherapy with Y-90-ibritumomab tiuxetan in extranodal marginal zone lymphoma


Dr Vanazzi discusses the trial investigating radioimmunotherapy with Y-90-ibritumomab tiuxetan in extranodal marginal zone lymphoma, a disease that currently has no standard treatment after primary th...



Author: ecancertv

Added: 04/22/2010


ECCO 15 - ESMO 34 Conference


Prof José Baselga, President of ESMO, discusses the ECCO 15 - ESMO 34 Conference in Berlin, September 2009.



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Cryopreservation of ovarian tissue


Prof Jacques Donnez of the Catholic University of Louvain, Brussels, Belgium, speaking at the ECCO 15 - ESMO 34 Conference about preserving fertility in young patients receiving treatment for ovarian ...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Potential prognostic value of isolated tumour cells in breast cancer sentinel nodes


Dr Marjut Leidenius from the Breast Surgery Unit, Helsinki University Central Hospital discusses her work with the prognostic value of isolated tumour cells in breast cancer sentinel nodes.



Speaki...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - European action against rare cancers


Dr Paolo Casali an Executive Commitee Member of the European Society for Medical Oncology discusses ESMO's new initiative to colate action against rare cancers across Europe



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Epidemiology of colorectal cancer and surgical treatment


Dr Gabriela Moeslein of St Josef's Hospital, Bochum-Linden, Germany, speaking at ECCO 15 - ESMO 34 in Berlin, 2009.



Familial risk of colorectal cancer, CAP study on aspirin for colorectal cancer p...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Hyper-reactions to radiotherapy


Dirk De Ruysscher, from the University Hospital Maastricht, Netherlands, discusses his work studying the genetics of patients and predicting reaction to radiotherapy, in order to improve efficiency.

...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Increasing prostate cancer awareness


Tom Hudson, Chair of Europa Uomo, discusses Europa Uomo's aim to increase awareness of prostate cancer and the importance of presenting symptoms.



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - European Action Against Rare Cancers


Kathy Oliver, Director of the International Brain Tumour Alliance, discusses the launch of the European Action Against Rare Cancers initiative, also her 'Walk around the world for brain tumours' fundr...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - The patient perspective


Jan Geissler, Director of the European Cancer Patient Coalition, discusses the ECCO 15 - ESMO 34 meeting, from a patients perspective, Berlin 2009.



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Importance of exchanging scientific information


Professor Jean-Yves Blay talks about the importance of the ECCO-ESMO meetings for bringing together scientists, researchers, oncologists and patients to exchange scientific information, which then lea...



Author: ecancertv

Added: 04/22/2010


ECCO-ESMO Patient advocacy symposium conclusions


Sandra Craine from the Chronic Myeloid Leukaemia Support Group, UK, discusses the conclusions of the patient advocacy symposium at ECCO 15- ESMO 34, Berlin , 2009.



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Breast cancer screening in older women


Professor Silvio Monfardini discusses the issue of screening ages for mammography, and the different standards across Europe. He suggests reasons why the screening age should be increased to over 70. ...



Author: ecancertv

Added: 04/22/2010


ECCO 15 ESMO 34 - Targeted agents in the treatment of advanced NSCLC


Targeted agents in the treatment of advanced NSCLC. New data on Zactima. Zactima in combination with standard chemotherapy. Immunotherapy and the MAGE-A3 vaccine.



Prof Johan Vansteenkiste of the L...



Author: ecancertv

Added: 04/22/2010


Relapsed and Refractory Lymphoma: What It's Like When the Unexpected Happens


Topics Include: Discovering the relapse. How is a relapse/recurrance different than initial diagnosis? How do I deal? Sadness, anger and unexpected anxiety



Author: lymphomaresearch

Added: 04/21/2010


What is a Clinical Trial?


Topics covered are: What are the Phases of a Clinical Trial? Participating in Clinical Trials; What do I need to know? Will my insurance cover the costs? Can I say "no" or drop out? Will I r...



Author: lymphomaresearch

Added: 04/21/2010


Relapsed or Refractory Aggressive Lymphomas Medical Aspects (Part 1)


Topics include: Difference between Hodgkin and Non-Hodgkin Lymphoma, what is relapsed or refractory disease and when can it happen? What are the treatment options for relapsed or refractory lymphoma? ...



Author: lymphomaresearch

Added: 04/21/2010


Lymphoma Research Foundation -Cutaneous Lymphoma Basics and Treatment Options


Having a cutaneous lymphoma in your 20s or 30s can create lifestyle and personal challenges that people with other types of cancer do not experience. These unique aspects of living with cutaneous lymp...



Author: lymphomaresearch

Added: 04/21/2010


Lymphoma Research Foundation Watchful Waiting


Watchful waiting is a treatment option commonly used for indolent lymphomas. It is a time of close follow-up and monitoring of ones disease, but a time when no active treatment (e.g., chemotherapy) is...



Author: lymphomaresearch

Added: 04/21/2010


Lymphoma Research Foundation Managing Fear and Uncertainty


Because indolent lymphomas often require a cycle of starting and stopping treatment, fear and uncertainty about when the lymphoma may recur and require treatment is common. This webcast addresses thes...



Author: lymphomaresearch

Added: 04/21/2010


Lymphoma Research Foundation Talking to Friends & Family


Issues related to friends and families are unique when you or someone you know is diagnosed with lymphoma in their 20s and 30s. Insight from other young adults and patient support professionals in thi...



Author: lymphomaresearch

Added: 04/21/2010


Milano 27-02-10 3° Convegno Nazionale AIG: Chirurgia della Malattia in Progressione


Dott. Vittorio Quagliuolo, Responsabile Sezione di Chirurgia dei Sarcomi

IRCCS Istituto Clinico Humanitas, Rozzano, Milano



Author: gistonline

Added: 04/21/2010


ECCO 15 ESMO 34 - The role of EONS, patient interaction and oncology nursing variations by country


Sarah Faithful - President of the European Oncology Nursing Society - Role of EONS at the conference, interactions between healthcare professionals and patients, and variation in oncology nursing by c...



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34 - Panel Discussion


A panel discussions at the ECCO 15 - ESMO 34 Cancer Conference in Berlin.



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34 - A new era of melanoma treatment


Prof Alexander Eggermont, President of the European CanCer Organisation, talks to Editor Gordon McVie about a new era of melanoma treatment, immunomodulation, combination immunotherapy, ipilimumab's u...



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34 - ANTI-CTLA-4: A new immunological approach


Dr Jeff Weber - Moffitt Cancer Center, Tampa, Florida, USA



Current challenges in the treatment of advanced melanoma satellite symposium: new approaches in advanced melanoma. Official joint ECCO 15 ...



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34: The Second Opinion Panel - a programme allowing Danish patients to receive specialist treatment abroad


Prof Heine Hansen talks about a pilot study called the Second Opinion Panel that has been set up with support from the Danish Health Minister. This study allows any cancer patients looking for a secon...



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34: Compounds to improve disease control in advanced breast cancer


Expert interview, conducted by Prof Gordon McVie, with Dr Peyman Hadji - Head of the Department of Endocrinology, Osteoporosis and Reproductive Medicine at Philipps-University of Marburg, Germany



O...



Author: ecancertv

Added: 04/21/2010


ECCO 15 - ESMO 34 News 20-21 September, 2009


Prof Gordon McVie - ecancer Managing Editor, gives his round up of the first two days of ECCO 15 - ESMO 34 Cancer Conference in Berlin.



Author: ecancertv

Added: 04/21/2010


ECCO 15 - ESMO 34 News 23rd September 2009


Prof Gordon McVie - ecancer Managing Editor, gives his final round up of the ECCO 15 - ESMO 34 Cancer Conference in Berlin.



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34 - Round up for second day of the ECCO 15 - ESMO 34 Cancer Conference in Berlin


Prof Gordon McVie - ecancer Managing Editor, gives his round up of the 2nd day of ECCO 15 - ESMO 34 Cancer Conference in Berlin.



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34 - International clinical trial establishes aspirin protects against colorectal cancer


Prof John Burn of the Institute of Human Genetics, Newcastle University, UK, talks to ecancer editor Prof Gordon McVie about the results and possibilities opened by his trial which investigated the ef...



Author: ecancertv

Added: 04/21/2010


Collaboration between Anals of Oncology, ESMO and JSMO


Prof Jan B Vermorken, Editor-in-chief of Anals of Oncology discusses the role the journal plays and speaks of planned future developments such as free online access to papers.



Prof Vermorken is jo...



Author: ecancertv

Added: 04/21/2010


ECCO and ESMO join forces


Alexander M.M. Eggermont president of ECCO, and José Baselga, president of ESMO, discuss the new initiative between their organisations



Author: ecancertv

Added: 04/21/2010


ECCO 15 ESMO 34: Novel hormonal agents in early breast cancer


Expert interview conducted by Prof Gordon McVie with Julie Doughty, MD - Consultant Breast and Endocrine Surgeon, Western Infirmary, Glasgow, Scotland.



Women diagnosed with breast cancer face the r...



Author: ecancertv

Added: 04/21/2010


SABCS 2009


Interview at SABCS



Author: cancerconnect

Added: 04/20/2010


ECCO 15 - ESMO 34: New targeted drugs for metastatic renal cell carcinoma


Expert interview conducted by Prof Gordon McVie with Dr Joaquim Bellmunt MD PhD - Section Chief, Solid Tumor Oncology, Hospital del Mar, Barcelona, Spain



Metastatic renal cell carcinoma (RCC) has p...



Author: ecancertv

Added: 04/20/2010


ECCO 15 - ESMO 34: Current Challenges in the Treatment of Advanced Melanoma


Satellite Symposium: New Approaches in Advanced Melanoma. Official joint ECCO 15 and 34th ESMO Multidisciplinary Congress Sponsored Satellite Symposium Held on 20th September 2009



Author: ecancertv

Added: 04/20/2010


ECCO 15 - ESMO 34: New insights in staging tools, surgical, and medical management of stage II-III melanoma


Prof Alexander M. M. Eggermont - Erasmus University, Rotterdam, the Netherlands



Satellite Symposium: New Approaches in Advanced Melanoma Official joint ECCO 15 and 34th ESMO Multidisciplinary Congr...



Author: ecancertv

Added: 04/20/2010


Milano 27-02-10 3° Convegno Nazionale AIG: Livello di Imatinib nel plasma


Dott. Daniele Morelli, Responsabile Medicina di Laboratorio

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano



Author: gistonline

Added: 04/20/2010


SABCS 2009: Could Targeting Breast Cancer Stem Cells Be the Answer?


Dr. Jenny Chang of Baylor College of Medicine discusses stem cell research in breast cancer.



Author: cancerconnect

Added: 04/20/2010


What is Colorectal Cancer?


Dr. Allyson Ocean discusses colorectal cancer.



Author: cancerconnect

Added: 04/19/2010


Colorectal Cancer: Treatment and Clinical Trials


Dr. Allyson Ocean discusses the treatment of colorectal cancer.



Author: cancerconnect

Added: 04/19/2010


Colorectal Cancer: Testing and Staging


Dr. Allyson Ocean discusses the diagnosis and staging of colorectal cancer.



Author: cancerconnect

Added: 04/19/2010


Highlights in store at the 7th European Breast Cancer Conference, 24 - 27 March


In anticipation of the many highlights in store at the 7th European Breast Cancer Conference, 24 - 27 March, key experts highlight the uniqueness of full patient integration at EBCC meetings and under...



Author: ecancertv

Added: 04/19/2010


Roundup of the 7th European Breast Cancer Conference, Barcelona


Although we can be optimistic thanks to the great advances that have been made in the field, there are still unacceptable levels of variation, with high cancer rates found in certain countries and soc...



Author: ecancertv

Added: 04/19/2010


EBCC 6: Conference highlights from Europa Donna


Susan Knox, Executive Director of Europa Donna, a Europe-wide coalition of affiliated groups of women that facilitates the exchange and spread of pertinent information concerning breast cancer through...



Author: ecancertv

Added: 04/19/2010


EBCC 6: Epigenetics in cancer care


Prof. Romano Danesi, Dept. of Internal Medicine, University of Pisa.



Prof Danesi discusses the rose of epigenetics in cancer care, the ways of predicting the response or toxicity of treatments such...



Author: ecancertv

Added: 04/19/2010


EBCC 6: Variations in treatments with aromatase Inhibitors


Professor Per Lønning, Medical Oncologist at the University of Bergen, discusses the differences between the aromatase inhibitors letrozole, anastrozole, and exemustane. Prof. Lonning also highlights ...



Author: ecancertv

Added: 04/19/2010


EBCC 6: Improving breast cancer care using biomarker tests.


Prof. Mitch Dowsett, Head of Department of Biochemistry at the Institute of Cancer Research, Royal Marsden, UK.



Prof. Dowsett discusses biomarker tests; what purpose they serve within cancer treatm...



Author: ecancertv

Added: 04/19/2010


EBCC 6: NHS spending on cancer


Prof. Mike Richards National Cancer Director, Department of Health, UK



Prof. Richards speaks about the amount of monet invested into cancer treatments in the UK and what are the priorities within t...



Author: ecancertv

Added: 04/19/2010


Milano 27-02-10 3° Convegno Nazionale AIG: La gestione della terapia e degli effetti collaterali


Dott. Alessandro Comandone, Responsabile SC Oncologia Medica

Presidio Sanitario Gradenigo, Torino



Author: gistonline

Added: 04/19/2010


EBCC6: Safety and efficacy of chemotherapy before surgery


Professor Michael Untch, University of Munich and Breast Cancer Centre.



Prof. Untch discusses his study into combining trastuzumab with neoadjuvant chemotherapy before surgery and surprising new da...



Author: ecancertv

Added: 04/16/2010


Prof Julie Gralow discusses her main points of interest from EBCC 6


Prof. Julie Gralow, Medical Oncology at the University of Washington School of Medicine and Fred Hutchinson Cancer Research Center.



Prof. Gralow speaks about her highlights from the conference. A l...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Conference highlights and future of breast cancer care


Prof. Emiel Rutgers, Netherlands Cancer Institute and EBCC 6 Conference Chair.



Prof Rutgers discusses conference highlights and future of breast cancer care including: the importance of frozen tumo...



Author: ecancertv

Added: 04/16/2010


EBCC 6: The importance of epigenetics in the future direction or breast cancer treatment


Prof. Anne-Lise Børresen-Dale, President of European Association of Cancer Research (EACR).



Prof. Børresen-Dale discusses the importance of a multi discipline approach to cancer treatment. It is st...



Author: ecancertv

Added: 04/16/2010


Breast cancer trials held at the European Institute of Oncology.


Prof. Aaron Goldhirsch, Director of The Department of Medicine, IEO, Milan



Prof. Goldhirsch speaking about the future of breast cancer trials. In the future trials may be held on a smaller scale an...



Author: ecancertv

Added: 04/16/2010


EBCC 6: New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients.


Professor Gunter von Minckwitz, Chairman of the German Breast Group.



Prof. von Minckwitz discusses a trial investigating the use of capecitabine as a chemotherapeutic drug to treat breast cancer. T...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Acupuncture for Tamoxifen-Induced Hot Flushes


Hot flushes caused by Taoxifen can be damaging to patients quality of life, and frequently prevent patients from getting a good nights sleep.



Mrs Jill Hervik, Physiotherapist and Acupuncturist at ...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Acupuncture as treatment for hot flushes in patients using anti-oestrogen medication.


Mrs Jill Hervik, Physiotherapist and Acupuncturist, Vestfold Central Hospital, Norway.



Mrs Hervik speaks about a study which has has successfully reduced the hot flushes commonly caused by anti-oe...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Giovanna Gatti outlines the aims of the Fondazione Umberto Veronesi (FUV)


Dr Giovanna Gatti explains the aims of FUV, these are primarily the diffussion of science to doctors, scientists and the general public, and to help the progress of science and peoples understanding o...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Roundup


Overview of the 6th European Breast Cancer Conference in Berlin, 15-19 April 2008, the most successful European Breast Cancer Conference yet.



Author: ecancertv

Added: 04/16/2010


ECCO and ESMO join forces


Michel Ballieu, CEO of ECCO, and Åge Schultz, Executive Director of ESMO, discuss the new collaboration between ECCO and ESMO and how this will help the progress of European oncology.



Author: ecancertv

Added: 04/16/2010


EBCC6: Chemotherapy for pregnant breast cancer patients


Dr Sibylle Loibl, German Breast Group.



Dr Sibylle Loibl discusses her research on chemotherapy for pregnant breast cancer patients and gives advice to doctors based on the findings.



Author: ecancertv

Added: 04/16/2010


EBCC6: Pregnant patients lose out in breast cancer treatment.


Dr. Sibylle Loibl discusses data that shows pregnant breast cancer patients do not receive the correct breast cancer treatment. Treating pregnant patients with chemotherapy did not compromise birth we...



Author: ecancertv

Added: 04/16/2010


EBCC6: Is an annual mammogram better than a three-yearly one.


Professor Roger Blamey discusses a trial conducted to find out if an annual mammogram better than a three-yearly one. The trial also aimed to decide if women should be screened up to the age of 75.



Author: ecancertv

Added: 04/16/2010


EBCC6: Safety and efficacy of chemotherapy before surgery


Professor Michael Untch, University of Munich and Breast Cancer Centre.



Prof. Untch discusses his study into combining trastuzumab with neoadjuvant chemotherapy before surgery and talks about using...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Upper age limits for effective breast mammograms.


Dr. Jacques Fracheboud discusses his research investigating upper age limits for effective breast mammograms.



The study concludes that mamagrams are effective up the the age of 75, and the extensi...



Author: ecancertv

Added: 04/16/2010


EBCC6: Obese women disadvantaged in both treatment and diagnosis.


Dr. Evandro de Azambuja discusses clinical trials that have shown obese women are disadvantaged in both treatment and diagnosis of breast cancer.



Author: ecancertv

Added: 04/16/2010


EBBC6: New strategies needed to deal with breast cancer and obesity.


Dr Elisabetta Rapiti, Geneva Cancer Registry, Switzerland.



Dr Elisabetta Rapiti discusses her findings on breast cancer and obesity and suggests new strategies are needed to deal with the problems,...



Author: ecancertv

Added: 04/16/2010


EBBC6: New strategies needed to deal with breast cancer and obesity.


Dr Elisabetta Rapiti, Geneva Cancer Registry, Switzerland.



Dr Elisabetta Rapiti discusses her findings on breast cancer and obesity and suggests new strategies are needed to deal with the problems,...



Author: ecancertv

Added: 04/16/2010


EBBC6: The benefits of pre-op MRI scans for all breast cancer patients


David Martinez-Cecilia, General Surgery Service, Spain



David Martinez-Cecilia discusses the benefits of pre-op MRI scans for all breast cancer patients



Author: ecancertv

Added: 04/16/2010


EBBC6: The benefits of pre-op MRI scans for all breast cancer patients


David Martinez-Cecilia, General Surgery Service, Spain.



David Martinez-Cecilia discusses the benefits of pre-op MRI scans for all breast cancer patients



Author: ecancertv

Added: 04/16/2010


EBCC 6: Findings on Lapatinib's role in tackling cancer stem cells


Dr. Angel Rodriguez, Lester and Sue Smith Breast Centre, Baylor College of Medicine, Houston - Speaking at the 6th European Breast Cancer Conference in Berlin - explains the research into Lapatinib's ...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Findings on Lapatinib's role in tackling cancer stem cells


Dr. Angel Rodriguez, Lester and Sue Smith Breast Centre, Baylor College of Medicine, Houston - Interviewed at the 6th European Breast Cancer Conference in Berlin - explains the research into Lapatinib...



Author: ecancertv

Added: 04/16/2010


EBCC6: New research shows no link between aromatase inhibitors and cardiovascular problems.


Dr Alain Monnier, Medical oncologist and head of the medical oncology department at the Centre Hospitalier de Belfort-Montbéliard.



Dr Monnier, speaking at the EBCC 6 conference in Berlin, explains ...



Author: ecancertv

Added: 04/16/2010


EBCC6: New research shows no link between aromatase inhibitors and cardiovascular problems.


Dr Alain Monnier, Medical oncologist and head of the medical oncology department at the Centre Hospitalier de Belfort-Montbéliard.



Dr Monnier, interviewed at the EBCC 6 conference in Berlin, explai...



Author: ecancertv

Added: 04/16/2010


EBCC 6: Gene expression arrays for determining breast cancer treatment.


Dimitry Nuyten, Department of Radiation Oncology and Diagnostic Oncology, Netherlands Cancer Institute, speaks at the EBCC 6 conference about the use of gene expression arrays to guide treatment of lo...



Author: ecancertv

Added: 04/16/2010


The role of funding and policies on innovation in cancer drug development


Professor Richard Sullivan, Chairman of the European Cancer Research Managers Forum, discusses the study he co-aut***d, reviewing innovation in cancer drug development. To read the paper go to http://...



Author: ecancertv

Added: 04/15/2010


UK cancer reform strategy: impact so far and next steps


Professor Richard Sullivan, from the King's Health Partners Integrated Cancer Centre at King's College London and former head of clinical programmes at Cancer Research UK, gives his round up of the We...



Author: ecancertv

Added: 04/15/2010


The experience of the Greater Manchester and Cheshire Cancer Network, and UK policy


Toni Mathie, Network Programme Director of the Greater Manchester and Cheshire Cancer Network, talks to ecancer about the impact of the UK's Cancer Reform Strategy in the North West, and future challe...



Author: ecancertv

Added: 04/15/2010


The UK's National Awareness and Early Diagnosis Initiative


National Awareness and Early Diagnosis Initiative's (NAEDI) current work and future. Interviewed at the UK's Cancer Reform Strategy Meeting, British Medical Association headquarters, London, 26th Jan ...



Author: ecancertv

Added: 04/15/2010


The future of cancer policy in the UK


Catherine Foot, from the King's Fund, discusses the challenges and future demands facing cancer care in the UK. Interviewed at the UK Cancer Reform Strategy meeting at the British Medical Association ...



Author: ecancertv

Added: 04/15/2010


ASH 2009: New target for myeloma


Dr Teru Hideshima talks about a new protein, B-Cell Lymphoma 6, as a possible new target for myeloma.



Author: ecancertv

Added: 04/15/2010


ASH 2009: Novel agents for multiple myeloma


Dr Shaji Kumar discusses the improvement in treatment of multiple myeloma with new novel agents, specifically bortezomib and lenalidomide.



Author: ecancertv

Added: 04/15/2010


ASH 2009: Tackling polyneuropathy associated with bortezomib


Dr Pieter Sonneveld discusses results of clinical trials and molecular biology work on specific side-effects of treatment, in particular polyneuropathy associated with bortezomib.



Author: ecancertv

Added: 04/15/2010


ASH 09: Studies comparing treatments for lymphoma


Dr Mathias Rummel of the University Hospital, Giessen, Germany, disucsses studies which have compared differnt lymphoma treatments.



Author: ecancertv

Added: 04/15/2010


ASH 2009: New regimens for elderly multiple myeloma patients


Dr Maria-Victoria Mateos discusses the data from a Phase III trial investigating various triplet and doublet regimens containing bortezomib in previously untreated elderly multiple myeloma patients. D...



Author: ecancertv

Added: 04/15/2010


ASH 09: Myeloid supressor cells


Prof. John Harlan talks about the latest in myeloid supressor cells and adapting immune response by targeting the tumour micro-environment.



Author: ecancertv

Added: 04/15/2010


ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma


Prof. Jesus Fernando San-Miguel discusses the Phase IB, Multi-Center, Open-Label Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma.



Author: ecancertv

Added: 04/15/2010


ASH 2009: The International Consortium on Acute Promyelocytic Leukemia


Dr Eduardo Rego talks about The International Consortium on Acute Promyelocytic Leukemia and its work in Latin America.



Author: ecancertv

Added: 04/15/2010


ASH 09: Adult acute lymphoblastic leukaemia


Prof. Anthony Goldstone talks about adult acute lymphoblastic leukaemia and whether donor bone marrow transplantation improves outcomes.



Author: ecancertv

Added: 04/15/2010


ASH 2009: T-cell therapies


Dr Catherine Bollard discusses novel T-cell therapies and the work of her laboratory.



Author: ecancertv

Added: 04/15/2010


ASH 2009: New treatments for multiple myeloma


Prof. Antonio Palumbo discusses the two papers he presented at ASH. The first, bortezomib, melphalan, prednisone and thalidomide followed by maintenance with bortezomib and thalidomide for initial tre...



Author: ecancertv

Added: 04/15/2010


ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma


Interview by Peter Goodwin in which Prof. Andrzej Jakubowiak discusses the RVDD trial, a 4-drug combination of bortezomib, lenalidomide, liposomal doxorubicin, and dexamethasone. Response rates seem i...



Author: ecancertv

Added: 04/15/2010


Multiple myeloma news from ASH 2009


ecancer round up of the multiple myeloma news to come out of the American Society of Hematology meeting in New Orleans 5-8th December 2009.



Author: ecancertv

Added: 04/15/2010


American Society of Hematology Meeting, 5-9th Dec 2009


American Society of Haematology Meeting, New Orleans, 5-9th December 2009. ecancer Managing Editor Gordon McVie gives his roundup of ASH 2009 news, excluding Multiple Myeloma, which can be found in a ...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Impact of common antidepressants on tamoxifen effectiveness


Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherlands



ASCO press conference: Two studies report differing results about whether the antidepressants, fluoxetine and par...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Maintenance therapy for NSCLC


Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, USA



ASCO press conference: A phase III trial finds that adding erlotinib (Tarceva) to bevacizumab-based (Avastin) mainte...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Patient accrual in clinical trials


Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA.



ASCO press conference: New research shows that the longer it takes to develop a cancer clinical trial, the less likely it i...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Therapeutic cancer vaccine prolongs survival for follicular lymphoma


Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA



ASCO 2009: Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma:



An eight-yea...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Experimental targeted therapy improves progression-free survival for advanced NSCLC


Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US



ASCO 2009: Experimental targeted therapy with vandetanib improves progression-free survival in patients with advanced non-small cell lung can...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Oestrogen and progestin therapy increases NSCLC risk


ASCO 2009: Rowan T. Chlebowski, MD, PhD - Harbor-UCLA Medical Center - Los Angeles: Menopausal hormone therapy with oestrogen and progestin linked to increased risk of death from non-small cell lung c...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Lung cancer patients lacking MSH2 DNA repair protein fare better with chemotherapy


Pierre Fouret, MD, PhD, Institut Gustave Roussy, Université Pierre et Marie Curie, Paris, France: Speaking at ASCO 2009:



Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Surgery unnecessary for majority of patients with advanced colorectal cancer


Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA - speaking at ASCO 2009 press conference:



New research shows that patients who are newly diagnosed with metastatic, surgi...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Low rates of screening among childhood cancer survivors


Dr. Paul Nathan - Hospital for Sick Children, Toronto, Canada - speaking at ASCO 2009 press conference:



Too few survivors of childhood cancer are getting recommended screenings for cancers of the ...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma


Patrick Hwu, MD, Chair of the Department of Melanoma Medical Oncology M. D. Anderson Cancer Center:



Therapeutic vaccine improves response rate and extends progression-free survival in patients wit...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Bevacizumab and standard adjuvant chemotherapy


ASCO 2009: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer.



Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny Gener...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Childhood cancer survivors at risk of post-traumatic stress disorder


Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles, California, USA - speaking at ASCO 2009 press conference:



Report shows that the incidence of post-traumatic stress d...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: PARP inhibitor BSI-201 plus chemotherapy: new option for triple-negative breast cancer


Joyce OShaughnessy, MD, Baylor-Charles A. Sammons Cancer Center, Dallas, Texas, speaking at ASCO 2009:



PARP inhibitor BSI-201 plus chemotherapy may offer new treatment option for triple-negative b...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Trial compares common adjuvant treatments for pancreatic cancer


Dr. John Neoptolemos - University of Liverpool, Liverpool, UK - speaking at the ASCO 2009 press conference:



A phase III trial comparing the adjuvant treatments most commonly used for pancreatic ca...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Lung cancer screening by low-dose computed tomography results in high rate of false positives


Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland, USA - speaking at ASCO press conference:



A new study finds that lung cancer screening using low-dose computed tomograp...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Treatment based on rising CA125 blood levels does not improve survival for ovarian cancer


Gordon Rustin, MD, Mount Vernon Cancer Center, Hertfordshire, United Kingdom, speaking at ASCO 2009:



Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian can...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Sentinel node biopsy is an effective less invasive option for early-stage cervical cancer patients


Fabrice Lecuru, MD, PhD, George Pompidou European Hospital, Paris, France, speaking at ASCO 2009:



Sentinel node biopsy is an effective, less invasive option for early-stage cervical cancer patients...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Standard treatment plus trastuzumab for HER2+ gastric cancer


Eric Van Cutsem, MD, PhD, University Hospital Gasthuisberg, Leuven, Belgium, speaking at ASCO 2009:



Adding trastuzumab to standard treatment improves survival in patients with HER2-positive gastric...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Prophylactic creams and antibiotics reduce severe drug-related skin rash


Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.



ASCO press conference: Giving colon cancer patients a combination of moisturisers, sunscreen, topical steroids and ...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Partial Breast Irradiation


Dr. Davide Mauri discusses trials that have shown the partial breast irradiation does not jeopardise survival or the risk of metastasis.



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Pemetrexed extends survival as maintenance therapy


Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA, speaking at the ASCO press conference:



A phase III study reports that maintenance therapy with pemetrexed (Alimta) ...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Oxaliplatin does not improve outcomes for rectal cancer


Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy - speaking at the ASCO press conference:



Adding oxaliplatin (Eloxatin) to standard treatment in patients with locally advanced rectal cancer does ...



Author: ecancertv

Added: 04/15/2010


Olaparib induces tumour response as single agent in BRCA-deficient breast cancer


Andrew Tutt, MB, ChB, PhD, Kings College London, United Kingdom, speaking at ASCO 2009:



PARP inhibitor olaparib induces tumour response as single agent in BRCA-deficient breast cancer: A small, Pha...



Author: ecancertv

Added: 04/15/2010


Combing radiotherapy, gemcitabine and cisplatin as treatment for cervical cancer.


Dr Alfonso Dueñas-González discusses the combination of gemcitabine and cisplatin chemotherapy with radiotherapy as a way of treating cervical cancer.



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Zoledronic acid for treament of prostate cancer


Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals.



Results of Phase II study comparing Orazol (zoledronic acid in oral form) to Zometa (zoledronic acid IV) injections in trea...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Bortezomib based therapies for myeloma


Dr Paul Richardson, Hematologic Oncology Dept, Dana-Farber Cancer Institute, speaking at ASCO 2009 about Bortezomib based therapies in relapsed and refractory myeloma. Tanespimycin with bortezomib (so...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Cancer prevention strategies


Professor Peter Boyle, International Prevention Research Institute.



Prof. Boyle discusses the issue of world cancer disparities such as risk factors and treatment and how the International Preventi...



Author: ecancertv

Added: 04/15/2010


Targeting death receptors in chemo-resistant cancer cells


Prof Patrick Johnston, Centre for Cancer Research & Cell Biology, Queen's University Belfast, discusses his work targeting the BCL2 protein family and other inhibitors of cell apoptosis in order t...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: PSA/Prostate screening


Dr. Otis W. Brawley - Chief Medical Officer, ACS.



Prostate cancer screening studies and ASCO 2009



Author: ecancertv

Added: 04/15/2010


ASCO 2009: Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients


Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland



Study to evaluate the frequency of complete pathologic response after neo-adjuvant treatment with cisplatin chemotherapy in women ...



Author: ecancertv

Added: 04/15/2010


ASCO 2009: PARP inhibitors show promise for hard-to-treat breast cancers


Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK

A study reports that women with BRCA deficient advanced breast cancer experienced tumour shrinkage after receiving...



Author: ecancertv

Added: 04/15/2010


The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues


Alexander M. M. Eggermont (NL), President of ECCO, Congress Chair and Oncopolicy Track; Co-Chair Kathy Oliver (UK), Co-Director of the International Brain Tumour Alliance; Maciej Krzakowksi (PL), The ...



Author: ecancertv

Added: 04/15/2010


ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?


Discover just some of the many reasons for attending the ECCO 15-ESMO 34 conference in Berlin.

A roundtable discussion with: Fatima Cardoso (BE), Co-Chair, Breast Cancer – Advanced Disease Track; Ra...



Author: ecancertv

Added: 04/15/2010


Pleural Mesothelioma | Dr. Julie Brahmer


http://www.curemeso.org... --- Video of Dr. Brahmer's presentation at the International Symposium on Malignant Mesothelioma 2009.



Author: mesothelioma_applied_research_foundation

Added: 04/12/2010


Peritoneal Mesothelioma | John Chabot, MD


http://www.curemeso.org... --- Video presentation from the International Symposium on Malignant Mesothelioma 2009.



Author: mesothelioma_applied_research_foundation

Added: 04/12/2010


Pleural Mesothelioma | Mesothelioma Applied Research Foundation


http://www.curemeso.org... ---- Video presentation of Dr. Flores at the International Symposium on Malignant Mesothelioma 2009.



Author: mesothelioma_applied_research_foundation

Added: 04/12/2010


Martin Kemp opens HCA Gamma Knife Centre


The actor and Spandau Ballet singer Martin Kemp has opened the revolutionary Gamma Knife Centre to treat brain tumours. The centre is a £3 million joint venture between HCA, the leading London private...



Author: hcacancercare

Added: 04/09/2010


The 100th CyberKnife Patient


A man from Greater London has become the 100th person to be treated at the UK's first CyberKnife Centre at the renowned Harley Street Clinic in London.



The man, who has been suffering from prostate...



Author: hcacancercare

Added: 04/09/2010


Neurosurgery at The Wellington Hospital


Lewis Thorne is a consultant neurosurgeon looking after patients at both The Wellington Hospital in St Johns Wood, London and the nearby Royal Free hospital in Hampstead. His specialist area of intere...



Author: hcacancercare

Added: 04/09/2010


Prof Martin Birchall - Advances in Technology


Prof Martin Birchall reviews the advances in technologies and treatments available for patients with voice and throat disorders, including the transnasal esophagoscope, intensity modulated therapy for...



Author: hcacancercare

Added: 04/08/2010


Prof Martin Birchall - Cancer of the Vocal Cords


Prof Martin Birchall discusses the case of a patient suffering from hoarseness and highlights the importance of early GP referrals in cases such as this. After performing an endoscopy, Prof Birchall i...



Author: hcacancercare

Added: 04/08/2010


Radiation Treatment: Safe and Effective for Patients


Radiation treatment plays a critical role in managing cancer, and advances in radiation oncology have been significant and steady since its first clinical application more that 65 years ago. Those of ...



Author: mdanderson

Added: 04/07/2010


Dr. Robert Uzzo M.D., Fox Chase Cancer Center, - management of small cell renal masses localized renal cell carcinnoma case presentation


Eighth International Kidney Cancer Symposium - Robert Uzzo, M.D., FACS. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is f...



Author: kidneycancer

Added: 04/05/2010


Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses small renal masses: partial nephrectomy


Eighth International Kidney Cancer Symposium - Paul Russo, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is freely av...



Author: kidneycancer

Added: 04/05/2010


Dr. Jeffrey Cadeddu M.D., UT Southwestern Medical Center - Small renal masses: thermal ablation


Eighth International Kidney Cancer Symposium - Jeffrey Caddedu, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is free...



Author: kidneycancer

Added: 04/05/2010


Dr. Michael Jewett, M.D., FACS Professor of Surgery, Division of Urology University of Toronto, - Small renal masses: active surveillance


Eighth International Kidney Cancer Symposium - Michael Jewett, M.D., FRCSC, FACS. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and v...



Author: kidneycancer

Added: 04/05/2010


Dr. Astrid Van der Veldt, M.D., VU University Medical Center, Amsterdam, Netherlands., talks about Choi criteria


Eighth International Kidney Cancer Symposium - Astrid Van der Veldt, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is...



Author: kidneycancer

Added: 04/05/2010


Dr. Allan Pantuck M.D., Ronald Reagan UCLA Medical Center, Management of Locally Advanced RCC Case Presentation


Eighth International Kidney Cancer Symposium - Allan Pantuck, M.D., F.A.C.S. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos...



Author: kidneycancer

Added: 04/05/2010


Dr. Michael Blute, M.D., UMass Memorial Health Care and UMass Medical School, Lymph Node Dissection


Eighth International Kidney Cancer Symposium - Michael Blute, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is freely...



Author: kidneycancer

Added: 04/05/2010


Dr. Eric Jonasch, M.D of MD Anderson talks about Neoadjuvant Therapy in locally advance disease


Eighth International Kidney Cancer Symposium - Eric Jonasch, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is freely ...



Author: kidneycancer

Added: 04/05/2010


Milano 27-02-10 3° Convegno Nazionale AIG: Aspetti etici della sperimentazione


Dott. Roberto Satolli, Presidente del Comitato Etico Indipendente della Fondazione IRCCS Istituto Nazionale dei Tumori, MIlano



Author: gistonline

Added: 03/31/2010


Milano 27-02-10 3° Convegno Nazionale AIG: La corretta diagnosi


Dott. Angelo Paolo Dei Tos, Direttore del Dipartimento di Oncologia

Azienda ULSS 9, Treviso



Author: gistonline

Added: 03/31/2010


Milano 27-02-10 3° Convegno Nazionale AIG: La chirurgia del residuo in risposta a Imatinib


Dott. Alessandro Gronchi, UO Sarcoma e Melanoma, Dipartimento di Chirurgia Fondazione IRCCS Istituto Nazionale Tumori Milano



Author: gistonline

Added: 03/24/2010


Milano 27-02-10 3° Convegno Nazionale AIG: Farmaci approvati, off-label e sperimentazioni


Dott. Paolo G. Casali, Responsabile SS Trattamento Medico Sarcomi Adulto

Fondazione IRCCS Istituto Nazionale dei Tumori, MIlano



Author: gistonline

Added: 03/24/2010


Axel Grothey - Colorectal and Non-Colorectal Gastrointestinal Cancers Event


Colorectal and Non-Colorectal Gastrointestinal Cancers:

Comprehensive Review and Update

Saturday, April 10, 2010

Program Director - Axel Grothey, MD, Professor of Oncology and Consultant, Mayo Clin...



Author: knaidu

Added: 03/23/2010


Deborah Armstrong, MD, Johns Hopkins Kimmel Cancer Center, discusses Early studies of enzastaurin and bevacizumab.


Full interview...

http://elc.imedex.com/?proj...



* Early studies of enzastaurin and bevacizumab

* Single nucleotitde polymorphisms (SNPs)

* BRCA1 and association with clinical...



Author: imedex

Added: 03/22/2010


Thomas J. Herzog, MD, Columbia University College of Physicians and Surgeons talks about liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced malignancy.


Full interview...

http://elc.imedex.com/?proj...



* Liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced malignancy

* Erlotinib in squamous cell carcinoma...



Author: imedex

Added: 03/22/2010


Carolyn Runowicz, MD, of University of Connecticut Health Center reveals the impact of quadrivalent vaccine in women with cervical cancer


Full interview...

http://elc.imedex.com/?proj...



* Cervical and endometrial cancer screening and prevention

* Impact of quadrivalent vaccine in women with cervical cancer



Author: imedex

Added: 03/22/2010


James T. Thigpen, MD, University of Mississippi Medical Center discusses CA125 use as a clinical indicator.


Full interview...

http://elc.imedex.com/?proj...



* Platinum sensitive, recurrent ovarian cancer studies

* Targeted agents

* CA125 use as a clinical indicator



Author: imedex

Added: 03/22/2010


The Division of Thoracic Surgery


The Division of Thoracic Surgery at Greater Baltimore Medical Center offers expertise in the general thoracic surgery field and includes cutting-edge multimodality cancer treatment and minimally invas...



Author: gbmc

Added: 03/22/2010


Bradley J. Monk, MD, University of California Irvine talks about role of bevacizumab – cost effectiveness analysis


Full interview...

http://elc.imedex.com/?proj...



* Optimal treatment of early-stage ovarian cancer

* Role of bevacizumab – cost effectiveness analysis

* Gynecologic Oncology ...



Author: imedex

Added: 03/22/2010


Robert L. Coleman, MD of the M. D. Anderson Cancer Center talks about intraperitoneal versus intravenous chemotherapy in ovarian cancer


Full interview...

http://elc.imedex.com/?proj...



* Intraperitoneal versus intravenous chemotherapy in ovarian cancer

* BRCA mutations in ovarian cancers

* American Congress o...



Author: imedex

Added: 03/22/2010


New ACS Guidelines on Screening for Prostate Cancer


Recently, the American Cancer Society updated its recommendations regarding screening for prostate cancer. They differ from recommendations of other organizations. This video discusses them and wha...



Author: prostatevideos

Added: 03/16/2010


Living with Fear: A Prostate Cancer Special


Follow Mike Robitaille, Buffalo Sabres hockey analyst, through his experience with a routine prostate cancer screening exam - or what he thought would be routine. This 30-minute TV special will air on...



Author: roswellpark

Added: 03/15/2010


Understanding Potential Side Effects after Treatment for Localized Prostate Cancer


Men weighing their options for localized prostate cancer need to know the odds that each side effect might occur. Ideally this information has been gathered from validated surveys completed by patient...



Author: prostatevideos

Added: 03/14/2010


Screening for Prostate Cancer- Should You or Shouldn't You


A discussion of the risks and benefits of screening for prostate cancer based on available scientific studies



Author: prostatevideos

Added: 03/14/2010


New Guidelines Regarding Active Surveillance of Low Risk Prostate Cancer


Active Surveillance is being recognized as an increasingly important option for men with a PSA less than 10 ng/ml, a Gleason score of 6 and a normal prostate exam. The question for patients is how str...



Author: prostatevideos

Added: 03/14/2010


Long Term Implications of PSA Testing


The PSA test has been available for approximately 20 years. The question for many is how beneficial has it been. A recent study assessed the overall impact in terms of additional cancers diagnosed and...



Author: prostatevideos

Added: 03/14/2010


Is Proton Radiation Safer or More Effective than Other Radiation for Localized Prostate Cancer.


Proton Beam Therapy has been used to treat many men with localized prostate cancer. In theory, it may be safer or better than photon radiation but the question is what is really known about it. A rece...



Author: prostatevideos

Added: 03/14/2010


Is Minimally Invasive Radical Prostatectomy Safer and_or More effective than Open Prostatectomy.


Considerable publicity surrounds the possible benefits of minimally invasive radical prostatectomy for prostate cancer. Unfortunately, no randomized studies have ever supported this claim. This video ...



Author: prostatevideos

Added: 03/14/2010


Is External Radiation Using the Calypso Tracking System Better than IMRT for prostate cancer.


One of the newer modifications for administering external beam radiation is the use of the Calypso Tracking system which constantly adjusts the beam to minimize radiation beyond the prostate gland. Ad...



Author: prostatevideos

Added: 03/14/2010


Indications and Extent of Pelvic Node Dissection for Men undergoing Radical Prostatectomy_1


Historically, pelvic nodes were removed in men undergoing radical prostatectomy to determine if the disease was more extensive. Most doctors performed a 'limited' dissection to minimize side effects. ...



Author: prostatevideos

Added: 03/14/2010


Hormone Therapy + XRT for Locally Advanced Prostate Cancer- What is the Best Duration.


Several studies have found that hormone therapy improves the survival of men with locally advanced prostate cancer who are treated with external radiation. Considerable debate has remained over what d...



Author: prostatevideos

Added: 03/14/2010


Watch this video in a new window Does Robotic Prostatectomy Cause More Impotence and Incontinence than Open Prostatectomy?


A recent study was published in the Journal of the American Medical Association in October, 2009 that compared results for open vs. minimally invasive radical prostatectomy. The authors found that min...



Author: prostatevideos

Added: 03/14/2010


Does Hormone Therapy Cause Heart Attacks in Men with Prostate Cancer?


Hormone therapy or reducing testosterone has clear benefits for patients with prostate cancer and significant side effects. One that has been more recently identified is the increased risk of cardiova...



Author: prostatevideos

Added: 03/14/2010


NCCN Prostate Cancer Guidelines


Mike Robitaille, Buffalo Sabres Hockey Analyst, urges men to learn about the updates made by the National Comprehensive Cancer Network (NCCN) to the prostate cancer treatment guidelines. Active survei...



Author: roswellpark

Added: 03/13/2010


Let's Talk about Prostate Cancer: Integrative Oncology (Gary Deng, MD PhD)


Many prostate cancer patients rely on complementary and/or alternative treatments. In this video, Dr. Gary Deng of the Integrative Oncology Department at Memorial Sloan Kettering Cancer Center shares ...



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer- Video Education Gerald Chodak MD


Dr. Chodak, a surgeon, is the founder of ProstateVideos.com, a long-time advocate for the appropriate application of techniques such as active surveillance, and the urologist who brought some patients...



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer: Public Education and Collaboration (Michael Scott)


E. Michael (Mike) D. Scott is a long-time prostate cancer activist and educator, co-founder of Prostate Cancer International and the Prostate Cancer Community Awareness Councils.

http://pcainterna......



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer with Charles "Snuffy" Myers, MD


Charles Snuffy Myers, MD is a fee for counsel medical oncologist, a prostate cancer patient, and founder of the American Institute for Diseases of the Prostate. He practices in Earlysville, VA, where ...



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer with Mark Scholz, MD


Mark Scholz, MD is a community-based medical oncologist practicing in Los Angeles, CA. He specializes exclusively in the treatment of men with prostate cancer. He is also a co-founder, an member of th...



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer with Lisa Chaiken MD


Dr. Lisa Chaiken is a community-based radiation oncologist who practices in Santa Monica, California. She talks about some of the recent developments in the roles of radiation therapy in the treatment...



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer with John Mulhall MD


Dr. John Mulhall of the Memorial Sloan-Kettering Cancer Institute talks about the relationship between prostate cancer treatment and erectile dysfunction and current mechanisms to manage the potential...



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer: Building Bridges (Arnon Krongrad, MD)


Dr. Krongrad is the Chairman of the Prostate Cancer Mission, a co-founder of Prostate Cancer International, and a highly regarded specialist in minimally invasive prostate surgery.



Author: pci

Added: 03/13/2010


Let's Talk about Prostate Cancer with Dr. David Heber, MD


David Heber, MD is the Director of the Center for Human Nutrition at UCLA. One of his special interests is the relationships between nutrition and cancer, and he has over 20 years of experience in thi...



Author: pci

Added: 03/13/2010


Donald Trump's pep talk to our Dr. Donald Trump


Donald Trump shared these words of encouragement for Dr. Donald Trump, CEO and President of Roswell Park, before he shaved both head and mustache at the kick off of the national Goin' Bald For Buck......



Author: roswellpark

Added: 03/13/2010


Let's Talk about Prostate Cancer: A Urologist With Prostate Cancer (Paul Schellhammer, MD)


Paul Schellhammer, MD, former President of the American Urological Association, is a long-time leading authority on the management of prostate cancer. Dr. Schellhammer talks about his own progressive ...



Author: pci

Added: 03/12/2010


Let's Talk about Prostate Cancer with Arthur Lurvey, MD


Dr. Arthur Lurvey is a member of the board of directors of the Prostate Cancer Research Institute and the California Prostate Cancer Coalition. He is also a medical director with a major California......



Author: pci

Added: 03/12/2010


Milano 27-02-10 3° Convegno Nazionale AIG: Apertura Convegno


Anna Costato Presidente AIG, Dr Gerolamo Corno direttore generale IRCCS Istituto Nazionale Tumori Milano, Dr Marco Pierotti direttore scientifico IRCCS Istituto Nazionale Tumori Milano



Author: gistonline

Added: 03/11/2010


Dr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses Novel Therapies for Prostate Cancer


Dr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses Novel Therapies for Prostate Cancer at ASCO GU Conference from San Francisco. Direct Link...http://elc.imedex.com/?proj......



Author: imedex

Added: 03/08/2010


Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic on Who are the candidates for prevention therapy?


Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic on "Who are the candidates for prevention therapy?" Direct Link...http://elc.imedex.com/?proj...



Author: imedex

Added: 03/08/2010


Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic are asked Screening-what are the guidelines and what do you recommend?


Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic are asked "Screening-what are the guidelines and what do you recommend?" Direct Link...http://elc.imedex.com/?pro......



Author: imedex

Added: 03/08/2010


Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses Renal Cell Cancer-Surgical management & high risk disease.


Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, New York discusses Renal Cell Cancer-Surgical management & high risk disease at the ASCO GU Conference 2010 Direct Link... http://elc.ime......



Author: imedex

Added: 03/08/2010


Dr. Gary Hudes, MD Fox Chase Cancer Center, discusses Management of advanced RCC


Dr. Gary Hudes, MD Fox Chase Cancer Center, in Philadelphia discusses Management of advanced Renal Cell Cancer at the 2010 ASCO GU Conference in San Francisco. Direct link...http://www.imedex.com...



Author: imedex

Added: 03/08/2010


Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, Discusses Bladder Cancer and Rare GU Tumors


Dr. Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, in New York Discusses Bladder Cancer and Rare GU Tumors at the ASCO Genitourinary Conference in San Francisco.

Direct link...http://el......



Author: imedex

Added: 03/08/2010


ONS Foundation at Congress 2010


Margaret Hansen Frogge, President of the ONS Foundation, talks about some of the events and opportunities that the Foundation will provide at the 35th annual ONS Congress in San Diego, CA, May 13-16, ...



Author: oncologynurses

Added: 03/02/2010


San Diego ONS Chapter is Wild About Congress


The San Diego chapter of ONS shares some reasons why they're wild about hosting the 35th annual ONS Congress in May 2010.



Author: oncologynurses

Added: 03/02/2010


ONS on NMR


An eight-minute segment produced by National Medical Report about the Oncology Nursing Society.



Author: oncologynurses

Added: 03/01/2010


Brenda Nevidjon on Health Care


ONS President Brenda Nevidjon urges nurses to get involved in the current health care debate.



Author: oncologynurses

Added: 03/01/2010


Heidi Lucas


Naturopathic physician Heidi Lucas explains naturopathic oncology, which she presented to the 2009 APN Conference in Tampa, FL on Friday, November 13, 2009.



Author: oncologynurses

Added: 03/01/2010


Patrick Coyne


Patrick Coyne from the VCU M***ey Cancer Center talking about his session on palliative care at the 2009 APN Conference in Tampa, FL.



Author: oncologynurses

Added: 03/01/2010


Cyndi Cramer


Cyndi Cramer talking about her subject for the ONS Trish Greene Quality of Life Lecture at the 2009 Institutes of Learning (IOL) in Tampa, FL



Author: oncologynurses

Added: 02/24/2010


Congress 2010 - Kristen Baileys


Kristen Baileys, president of the Greater Pittsburgh Chapter of ONS, talks about the upcoming 35th annual ONS Congress in San Diego, CA.



Author: oncologynurses

Added: 02/24/2010


Multiple Myeloma and Oncology Nurses


Kena Miller, MSN, FNP describes the critical role of nurses in the treatment and management of multiple myeloma. ManagingMyeloma.com has increased our nurse focus in 2010 with more nurse-specific cont...



Author: managingmyeloma

Added: 02/22/2010


Dr Richardson on Managing Myeloma


A video teaser for ManagingMyeloma.com, by national thought leader, Dr. Paul Richardson. Go to http://www.managingmyeloma.... to view theme month videos and listen to expert analysis of the practice ...



Author: managingmyeloma

Added: 02/22/2010


Pat Neal, RN with Ginger Sawyer and Carol Gangstead: Side effects of Tyrosine Kinase Inhibitors


.



Author: gistsupport

Added: 02/16/2010


Haesun Choi, MD: Radiologic imaging: Responding or Not Responding -- Lessons from the GIST Model


Lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center



Author: gistsupport

Added: 02/15/2010


Ask the Expert Session featuring Haesun Choi, MD and Pat Neal, RN


.



Author: gistsupport

Added: 02/14/2010


CytoCare - The better way to compound hazardous IVs


CytoCare automates the compounding of hazardous IVs used for chemotherapy, monoclonal antibody therapy, and genetic therapy. The result:



- Better patient care – Automated compounding improves accu...



Author: mckesson

Added: 02/11/2010


Annals of Oncology: An introduction


Editor-in-Chief Prof. Jan B. Vermorken outlines his vision for the journal Annals of Oncology, along with some recent and forthcoming developments. Dr. Nagahiro Saijo, President Emeritus of the Japane...



Author: annals_oncology

Added: 02/11/2010


Georgia Cancer Specialists's Totes 2 Tots Suitcase Drive for Foster Kids


Every year, Georgia Cancer Specialists hosts the Totes 2 Tots suitcase drive for Georgia's foster children. This year, more than 4,200 bags were collected. In the eight years since the program's incep...



Author: georgia_cancer_specialists

Added: 02/10/2010


7 Things You Should Know About Lung Cancer


Georgia Cancer Specialists physician Dr. Rodolfo Bordoni shares seven things you should know about lung cancer.



Author: georgia_cancer_specialists

Added: 02/10/2010


7 Things You Can Do if a Loved One is Diagnosed with Cancer


Georgia Cancer Specialists nurse Kimberly Auriemma shares seven things you can do if one of your loved ones is diagnosed with cancer.



Author: georgia_cancer_specialists

Added: 02/10/2010


7 Things You Should Know About Breast Cancer


Dr. Bruce Feinberg, president and CEO of Georgia Cancer Specialists, shares seven things you should know about breast cancer.



Author: georgia_cancer_specialists

Added: 02/10/2010


7 Things You Should Know About Colon Cancer


Dr. Bruce Feinberg, president and CEO of Georgia Cancer Specialists, shares seven very important things you should know about colon cancer.



Author: georgia_cancer_specialists

Added: 02/10/2010


Recently Diagnosed with Cancer? 7 Reasons You Should Have Hope


Georgia Cancer Specialists physician Dr. Jayanthi Srinivasiah (Dr. Jay) shares seven reasons you should have hope if you were recently diagnosed with cancer.



Author: georgia_cancer_specialists

Added: 02/10/2010


Georgia Cancer Specialists is Your Breast Cancer Answer


Learn why Georgia Cancer Specialists is your breast cancer answer.



Author: georgia_cancer_specialists

Added: 02/10/2010


Ask the Experts session featuring Suzanne George, MD; Laura Nolden, MS; and Tony Conley, MD


Panel Discussion from the 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer enter



Author: gistsupport

Added: 02/05/2010


Suzanne George, MD: The Role of Drug Plasma Level Testing in Metastatic GIST


lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center



Author: gistsupport

Added: 02/05/2010


Peter Pisters, MD FACS: Adjuvant therapy and surgical management of GIST


lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center



Author: gistsupport

Added: 02/04/2010


Jon Trent, MD: New Therapies for GIST


lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center



Author: gistsupport

Added: 02/04/2010


Wells Messersmith, MD, ASCO GI 2010


Dr Axel Grothey interviews Dr. Wells Messersmith from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on...



Author: imedex

Added: 02/01/2010


Cathy Eng, MD, FACP, ASCO GI 2010


Dr Axel Grothey interviews Dr. Cathy Eng from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on clinica...



Author: imedex

Added: 02/01/2010


Andrew X. Zhu, MD, PhD - ASCO GI 2010


Dr Axel Grothey interviews Dr. Andrew X. Zhu from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on cli...



Author: imedex

Added: 02/01/2010


Fighting Drug Resistance in CML


Dr. Richard Larson talks about patients concerns over drug resistance and the role of old drugs.



Author: patientpower

Added: 12/16/2009


Research on the Horizon for Hematologic Malignancies


Dr. Alan Gewirtz discusses research and new strategies for harnessing the immune system.



Author: patientpower

Added: 12/16/2009


An Expert's Perspective on the Latest CLL News


Dr. Michael Keating discusses the extended data and therapeutic challenges surrounding CLL.



Author: patientpower

Added: 12/16/2009


New Drug Combinations in CLL and Promising Research


Dr. Thomas Kipps discusses new agents and drug combinations being used to treat CLL.



Author: patientpower

Added: 12/16/2009


Bendamustine + Rituxan vs. CHOP + R for Indolent Lynphomas


Dr. Mathias Rummel talks about a new study showing how one old drug combined with a new drug is showing promise over the standard approach.



Author: patientpower

Added: 12/16/2009


Multiple Myeloma Maintenance Therapy


Dr. Maria-Victoria Mateos talks about a new study from Spain revealing how lower doses of newer drugs can be used in the long-term to fight cancer with much lower side effects.



Author: patientpower

Added: 12/15/2009


Vaccine Therapy for Blood Related Cancers


Dr. Carl June discusses promising research surrounding vaccine therapy for patients with blood related cancers.



Author: patientpower

Added: 12/15/2009


On the Horizon: Chemo Drugs No Longer Needed?


Dr. Ronald Levy talks about the possibility of no longer needing chemo and the role of antibodies.



Author: patientpower

Added: 12/15/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 W. Frasier Symmans, MD


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 W. Frasier Symmans, MD



Author: imedex

Added: 12/15/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Stephen F. Sener, MD


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Stephen F. Sener, MD



Author: imedex

Added: 12/15/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Hope S. Rugo, MD


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Hope S. Rugo, MD



Author: imedex

Added: 12/15/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Ruth O'Regan, MD


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Ruth O'Regan, MD



Author: imedex

Added: 12/15/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 William Gradishar, MD, FACP


2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Friday December 11, 2009 William Gradishar, MD, FACP



Author: imedex

Added: 12/14/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Thursday December 10, 2009 Mary Cianfrocca, DO


2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Thursday December 10, 2009 Mary Cianfrocca, DO



Author: imedex

Added: 12/14/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Harold Burstein, MD, PhD


2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Friday December 11, 2009 Harold Burstein, MD, PhD



Author: imedex

Added: 12/14/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Thursday December 10, 2009 George T. Budd, MD


2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Thursday December 10, 2009 George T. Budd, MD



Author: imedex

Added: 12/14/2009


San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Kimberly Blackwell, MD


Best of the Day from the 2009 San Antonio Breast Cancer Symposium (SABCS) - Friday December 11, 2009 Kimberly Blackwell, MD



Author: imedex

Added: 12/14/2009


ASH 2009 Best of the Day - Tuesday, December 8, 2009 Gail J. Roboz, MD


ASH 2009 Best of the Day - Tuesday, December 8, 2009 Gail J. Roboz, MD



Author: imedex

Added: 12/14/2009


ASH 2009 Best of the Day - Monday, December 7, 2009 Vincent Rajkumar, MD


ASH 2009 Best of the Day - Monday, December 7, 2009 Vincent Rajkumar, MD



Author: imedex

Added: 12/14/2009


ASH 2009 Best of the Day - Tuesday, December 8, 2009 Owen A. O'Connor, MD, PhD


ASH 2009 Best of the Day - Tuesday, December 8, 2009 Owen A. O'Connor, MD, PhD



Author: imedex

Added: 12/14/2009


ASH 2009 Best of the Day - Monday, December 7, 2009 Susan O'Brien, MD


ASH 2009 Best of the Day - Monday, December 7, 2009 Susan O'Brien, MD



Author: imedex

Added: 12/14/2009


Ruben A. Mesa, MD, ASH 2009 Best of the Day - Monday, December 7, 2009


ASH 2009 Best of the Day - Monday, December 7, 2009 Ruben A. Mesa, MD



Author: imedex

Added: 12/14/2009


ASH 2009 Best of the Day - Myron Czuczman, MD, Sunday, December 6, 2009


ASH 2009 Best of the Day - Myron Czuczman, MD, Sunday, December 6, 2009



Author: imedex

Added: 12/14/2009


ASH 2009 Best of the Day - Monday, December 7, 2009 Jorge Cortes, MD


ASH 2009 Best of the Day - Monday, December 7, 2009 Jorge Cortes, MD



Author: imedex

Added: 12/14/2009


ASH 2009 Best of the Day - Monday, December 7, 2009 Kenneth Anderson, MD, MA


ASH 2009 Best of the Day - Monday, December 7, 2009 Kenneth Anderson, MD, MA



Author: imedex

Added: 12/14/2009


Gary Schiller, MD, ASH 2009 Best of the Day - Tuesday, December 8, 2009


ASH 2009 Best of the Day - Tuesday, December 8, 2009 Gary Schiller, MD



Author: imedex

Added: 12/14/2009


Jeffrey N. Weitzel, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium


This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...



Author: imedex

Added: 11/29/2009


Stephen F. Sener, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium


This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...



Author: imedex

Added: 11/29/2009


Allen Lipton, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium


This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...



Author: imedex

Added: 11/29/2009


Marjorie Green, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium


This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...



Author: imedex

Added: 11/29/2009


Rowan T. Chlebowski, MD, PhD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium


This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...



Author: imedex

Added: 11/29/2009


Harold Burstein, MD, PhD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium


This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...



Author: imedex

Added: 11/29/2009


Stephen Schuster, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies


These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...



Author: imedex

Added: 11/29/2009


Martin Hutchings, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies


These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...



Author: imedex

Added: 11/29/2009


Jean-Luc Harousseau, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies


These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...



Author: imedex

Added: 11/29/2009


Rafael Fonseca, MD , Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies


These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...



Author: imedex

Added: 11/29/2009


Volker Diehl, MD , Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies


These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...



Author: imedex

Added: 11/29/2009


Kanti Rai, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies


These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...



Author: imedex

Added: 11/29/2009


ASH 2008 Interview Dr. Ferrajoli


Radon therapy in Switzerland



Author: imedex

Added: 05/13/2009


Oreilly ASCO Gastro Intestinal Interview


Interview with Dr. Oreilly



Author: imedex

Added: 05/13/2009


Help: How to Play a Video on OncologyTube and Features


In this tutorial we'll show you how to play a video on OncologyTube and some of the features of the player such as scrubbing and full screen mode.



Author: help

Added: 04/05/2008


Help: How to Post a Comment on a Video


In this tutorial we'll show you how to post a comment on a video.



Author: help

Added: 04/05/2008


Help: Send a Link to a Friend


In this tutorial we'll be covering how to use the "Video URL" link to send someone a direct link to a video on OncologyTube via email.



Author: help

Added: 04/05/2008


Help: Embedding OncologyTube Videos on an External Site


In this tutorial we will show you how to use the embed tag to have the video play on an external site.



Author: help

Added: 04/05/2008


Help: Adding Power Point Slides and Transcripts


In this tutorial we will go over how to attach downloadable Power Point slides and transcripts to a video hosted on OncologyTube.



Author: help

Added: 04/05/2008


Help: How to Subscribe to a Channel


You may find some particular content providers on OncologyTube worth getting updates about. In this tutorial we show you how to subscribe and unsubscribe to someone's channel and the general benefits.



Author: help

Added: 04/05/2008


Help: How to Customize the Look of My Channel


In this tutorial we go over how to change the colors and rearrange videos on your channel. There are many other modifications that can be made to a channel on OncologyTube to personalize it for you, ...



Author: help

Added: 04/05/2008


Help: How to Delete a Video


In this quick tutorial we'll show you how to permanently delete a video you have uploaded to OncologyTube.



Author: help

Added: 04/05/2008


Help: How to Make Changes to My Account


In this tutorial we describe how to make corrections or alterations to your account including changing email address, p***word, uploading a picture, adding your website, and other data to your account...



Author: help

Added: 04/05/2008


Help: How to Set Up an Account (It's Free!)


In this tutorial we will go through how easy and quick it is to set up a free account with OncologyTube. Once you set up an account you can upload your own videos, comment on other videos and a host o...



Author: help

Added: 04/05/2008


Help: Uploading Videos


Learn how to upload videos on OncologyTube.com. This tutorial goes over the 2 step process for uploading videos to OncologyTube.com. Formats we accept are FLV, Mpeg, QuickTime, and AVI.



Author: help

Added: 04/05/2008


Help: How do I Search or Browse for Videos?


In this tutorial we go over the differences between searching and browsing for videos on OncologyTube and the strengths or both.



Author: help

Added: 04/05/2008


No comments:

Post a Comment